Eastover Investment Advisors’s Amgen AMGN Stock Holding History

Eastover Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-790	Closed	-$259K	–	51
2025 Q4	$259K	Buy	+790	New	+$251K	0.11%	43

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Eastover Investment Advisors's AMGN Position: Q1 2026 in Review

Eastover Investment Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 790 shares — an estimated $259K sold.

Eastover Investment Advisors first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $259K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Eastover Investment Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Eastover Investment Advisors sold 790 Amgen shares in Q1 2026, an estimated $259K.
Eastover Investment Advisors first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
Eastover Investment Advisors's Amgen position peaked at $259K in Q4 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Eastover Investment Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.